TABLE 3.
Glucoregulatory biomarkers, insulin growth factors, and thyroid function after consumption of the carbohydrate (CHO), whey protein (WP), or soy protein (SP) supplement in overweight or obese adult men and women12
| Treatment |
|||
| CHO | WP | SP | |
| Glucose, log(mmol/L) | 0.255 ± 0.001 | 0.255 ± 0.001 | 0.255 ± 0.001 |
| Insulin, log(pmol/L) | 18.3 ± 0.3b | 16.3 ± 0.6a | 17.2 ± 0.3a |
| Ghrelin, ng/L | 870 ± 23b | 752 ± 36a | 837 ± 23b |
| IGF-I, μg/L | 77.8 ± 1.4a | 81.5 ± 2.1a | 87.0 ± 1.3b |
| IGFBP-1, ng/L | 721 ± 6 | 717 ± 11 | 719 ± 6 |
| IGFBP-3, mg/L | 1.98 ± 0.03b | 1.82 ± 0.05a | 2.04 ± 0.03b |
| T3 uptake, % | 31.4 ± 0.4ab | 30.9 ± 0.5a | 32.5 ± 0.4b |
| Free T4,pmol/L | 14.1 ± 0.1a | 13.7 ± 0.1a | 14.5 ± 0.3b |
All values are least squares means ± SEM, = 73 (39 women, 34 men). Means without a common letter differ.
Plasma glucose, insulin, ghrelin, IGF-I, IGFBP-1, IGFBP-3, and serum T3 uptake and T4.